Cargando…

Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma

MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression and function in tumor development and progression. We previously identified up-regulated miRNAs in clear cell renal cell carcinoma (ccRCC) compared to matched-pair normal kidney by microarray. Here, we identify miRNAs that are up-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Wataru, Uemura, Motohide, Sato, Mototaka, Fujita, Kazutoshi, Jingushi, Kentaro, Ueda, Yuko, Kitae, Kaori, Tsujikawa, Kazutake, Nonomura, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673293/ https://www.ncbi.nlm.nih.gov/pubmed/26046464

Ejemplares similares

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016)

Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma
por: Kinouchi, Toshiro, et al.
Publicado: (2017)

MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2017)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

ALKBH4 is a novel enzyme that promotes translation through modified uridine regulation
por: Kogaki, Takahiro, et al.
Publicado: (2023)

AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells
por: Ueda, Yuko, et al.
Publicado: (2017)

A real-time PCR-based quantitative assay for 3-methylcytosine demethylase activity of ALKBH3
por: Ueda, Yuko, et al.
Publicado: (2016)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1
por: Monoe, Yuya, et al.
Publicado: (2021)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Erectile Dysfunction in Germ Cell Tumor Survivors
por: Okada, Koichi, et al.
Publicado: (2021)

ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
por: Jingushi, Kentaro, et al.
Publicado: (2021)

MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
por: Hirono, Takayuki, et al.
Publicado: (2019)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
por: Maegawa, Yoko, et al.
Publicado: (2020)

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2018)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

Correction to: Primary adrenal lymphoma: three case reports and review of Japanese cases
por: Nakazawa, Shigeaki, et al.
Publicado: (2018)

Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
por: Uemura, Toshihiro, et al.
Publicado: (2023)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2018)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2016)

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment
por: Tani, Masaru, et al.
Publicado: (2022)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

Bladder urothelium converts bacterial lipopolysaccharide information into neural signaling via an ATP-mediated pathway to enhance the micturition reflex for rapid defense
por: Ueda, Norichika, et al.
Publicado: (2020)

FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab
por: Kawashima, Atsunari, et al.
Publicado: (2021)

Decreased renal function increases the nighttime urine volume rate by carryover of salt excretion to the nighttime
por: Takezawa, Kentaro, et al.
Publicado: (2021)

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

Secondary immune thrombocytopenic purpura with renal cell carcinoma
por: Nakazawa, Shigeaki, et al.
Publicado: (2019)

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers
por: Tomiyama, Eisuke, et al.
Publicado: (2021)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2018)

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
por: Hayashi, Takuji, et al.
Publicado: (2019)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lb4oc6lh9h1cmhag422p1lo7q3